Teva API – Sicor Site
Rho, Italy
- Blocks
- 7
- Area
- 240,000 sq.ft
Teva Active Pharmaceutical Ingredients Division
Global API division of Teva Pharmaceuticals — one of the world's largest API portfolios with deep regulatory coverage and CDMO depth across 17 sites.
APINEXA verifies every manufacturer for compliance, regulatory documentation availability, and active export capability before listing.
Teva API is the API division of Teva Pharmaceutical Industries, supplying APIs and intermediates to generic, branded and innovator pharmaceutical companies globally. With one of the broadest API portfolios in the industry and significant R&D investment, Teva API operates 17 manufacturing facilities across Europe, North America and Asia, all maintained under stringent USFDA, EU GMP and EDQM regulatory oversight.
Production capacity, technology platforms, and clean-room infrastructure verified at the manufacturer source.
A curated view of marquee molecules supplied by this manufacturer. Filter by therapeutic area to narrow results.
CAS 134523-03-8
CAS 910463-68-2
CAS 191732-72-6
CAS 147098-20-2
Authority-by-authority regulatory standing for major regulated and semi-regulated pharmaceutical markets.
| Region | Authority | Status |
|---|---|---|
United States | USFDA | Approved |
Europe | EU GMP / EDQM | Approved |
Japan | PMDA | Approved |
Canada | Health Canada | Approved |
Australia | TGA | Approved |
Israel | MOH Israel | Approved |
Live supply footprint grouped by market regulatory class — Regulated, Semi-Regulated, and Emerging.
No countries in this category.
No countries in this category.
Active commercial exports across regulated markets, with documentation packs available per region.
Each facility is verified for clean-room class, production blocks, and built-up area.
Rho, Italy
Netanya, Israel
Beersheba, Israel
MOQ flexibility, lead times, packaging formats, and supply-flexibility signals to support procurement teams.
Secure document access. Restricted documents require an NDA submitted through the RFQ form.
Send a structured inquiry routed through APINEXA's coordination team — confidential, compliance-pre-checked, audit-grade. Typical response in 6 hours.